Stem Cell Research in Cell Transplantation: Sources, Geopolitical Influence, and Transplantation
Authors:
- 1 November 2010
- journal article
- research article
- Published by SAGE Publications in Cell Transplantation
- Vol. 19 (11) , 1493-1509
Abstract
If the rapidly progressing field of stem cell research reaches its full potential, successful treatments and enhanced understanding of many diseases are the likely results. However, the full potential of stem cell science will only be reached if all possible avenues can be explored and on a worldwide scale. Until 2009, the US had a highly restrictive policy on obtaining cells from human embryos and fetal tissue, a policy that pushed research toward the use of adult-derived cells. Currently, US policy is still in flux, and retrospective analysis does show the US lagging behind the rest of the world in the proportional increase in embryonic/fetal stem cell research. The majority of US studies being on either a limited number of cell lines, or on cells derived elsewhere (or funded by other sources than Federal) rather than on freshly isolated embryonic or fetal material. Neural, mesenchymal, and the mixed stem cell mononuclear fraction are the most commonly investigated types, which can generally be classified as adult-derived stem cells, although roughly half of the neural stem cells are fetal derived. Other types, such as embryonic and fat-derived stem cells, are increasing in their prominence, suggesting that new types of stem cells are still being pursued. Sixty percent of the reported stem cell studies involved transplantation, of which over three quarters were allogeneic transplants. A high proportion of the cardiovascular systems articles were on allogeneic transplants in a number of different species, including several autologous studies. A number of pharmaceutical grade stem cell products have also recently been tested and reported on. Stem cell research shows considerable promise for the treatment of a number of disorders, some of which have entered clinical trials; over the next few years it will be interesting to see how these treatments progress in the clinic.Keywords
This publication has 134 references indexed in Scilit:
- Recent Advances of Dendritic Cells (DCs)-Based Immunotherapy for Malignant GliomasCell Transplantation, 2009
- Transplantation of Endothelial Progenitor Cells as Therapeutics for Cardiovascular DiseasesCell Transplantation, 2009
- Naive Rat Amnion-Derived Cell Transplantation Improved Left Ventricular Function and Reduced Myocardial Scar of Postinfarcted HeartCell Transplantation, 2009
- Percutaneous Cell Delivery into the Heart Using Hydrogels Polymerizing in SituCell Transplantation, 2009
- Ex Vivo Nanofiber Expansion and Genetic Modification of Human Cord Blood-Derived Progenitor/Stem Cells Enhances VasculogenesisCell Transplantation, 2009
- Autologous Bone-Marrow Mononuclear Cell Transplantation after Acute Myocardial Infarction: Comparison of Two Delivery TechniquesCell Transplantation, 2009
- Cardiac Stem Cell Therapy: Advances from 2008Cell Transplantation, 2009
- Hypothalamic Proline-Rich Polypeptide Enhances Bone Marrow Colony-Forming Cell Proliferation and Stromal Progenitor Cell DifferentiationCell Transplantation, 2008
- Comparison of Human Serum with Fetal Bovine Serum for Expansion and Differentiation of Human Synovial MSC: Potential Feasibility for Clinical ApplicationsCell Transplantation, 2008
- Stem Cell Research and Health EducationAmerican Journal of Health Education, 2008